S&P 500 5,235.18 +1.02%EUR/USD 1.0840 +0.21%GBP/USD 1.2710 +0.14%USD/JPY 149.50 −0.18%BRENT $82.40 −0.81%BTC $67,800 −0.21%GOLD $2,341 +0.55%NASDAQ 16,420.55 +0.74%S&P 500 5,235.18 +1.02%EUR/USD 1.0840 +0.21%GBP/USD 1.2710 +0.14%USD/JPY 149.50 −0.18%BRENT $82.40 −0.81%BTC $67,800 −0.21%GOLD $2,341 +0.55%NASDAQ 16,420.55 +0.74%
A daily business newspaper · Founded in 2026

Money Talk

Finance and markets: business, quotes, gold, energy and releases.

Halper Sadeh Probes Potential Fiduciary Breaches at TCBK, CLRO, and SOLS

Investor rights law firm Halper Sadeh LLC has launched investigations into TriCo Bancshares, ClearOne, and Solstice Advanced Materials to determine if recent merger agreements prioritize insider interests over shareholder value. The firm is scrutinizing whether these proposed transactions unfairly restrict competing offers or violate federal securities laws.

Halper Sadeh Probes Potential Fiduciary Breaches at TCBK, CLRO, and SOLS
Photo: Bio & News

The investigation focuses on the terms governing three separate corporate deals. For TriCo Bancshares (TCBK), the firm is reviewing the sale to First Hawaiian, Inc., which grants TriCo shareholders roughly 35% of the combined entity. Regarding ClearOne (CLRO), the inquiry targets the merger with Cortigent, Inc., where existing shareholders are slated to retain between 12.7% and 14.4% of the new equity. Solstice Advanced Materials (SOLS) is similarly under review following its announced merger with Element Solutions.

Halper Sadeh LLC suggests that these transactions may contain provisions that discourage superior bids, potentially depriving investors of better returns. The firm is currently evaluating whether to pursue increased consideration or enhanced disclosures on behalf of affected shareholders. Attorneys Zachary Halper and Daniel Sadeh are managing the inquiries from their New York office, operating on a contingent fee basis for those seeking legal recourse.

Share article
TelegramXFacebook

When reusing this material a link to Money Talk is required.

Comments (0)

Leave a comment

No comments yet. Be the first!